三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
ARX788市场空间测算
ARX788市场空间测算
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:317KB
图片尺寸:2303*1421
同报告图片
/
4
所属报告:
【公司研究】浙江医药-维生素与原料:制剂一体化双轮驱动创新药ADC即将步入Ⅱ、Ⅲ期-20200702[25页].pdf
打包全文图表
相关数据
ARX788乳腺癌关键II/III期临床研究数据在2024年ASCO口头汇报
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
收藏
行业数据
2024-08-19
原图定位
查看详情
相较DS-8201,ARX788显示出更优的安全性
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
收藏
行业数据
2023-07-04
原图定位
查看详情
ARX788临床数据至市场表现回升
fCDml6XmnJ8gfCDogqHku7fvvIjnvo7lhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS18CnwgMjAyMi80LzE4IHwgNC4wMCB8CnwgMjAyMi82LzE4IHwgMy41MCB8CnwgMjAyMi84LzE4IHwgMi41MCB8CnwgMjAyMi8xMC8xOCB8IDIuMDAgfAp8IDIwMjIvMTIvMTggfCAxLjUwIHwKfCAyMDIzLzIvMTggfCAxMi4wMCB8CnwgMjAyMy8zLzEgfCAxNC4wMCB8CnwgMjAyMy8zLzYgfCAxMy4wMCB8CgrotYTmlpnmnaXmupDvvJp3aW5k77yMQW1icm945YWs5ZGK77yM5Zu96YeR6K+B5Yi456CU56m25omA
收藏
行业数据
2023-07-04
原图定位
查看详情
ARX788在HER2阳性乳腺癌患者的末线治疗的适应症DCF估值约35亿元
fCDljZXkvY0gfCAyMDI0RSB8IDIwMjVFIHwgMjAyNkUgfCAyMDI3RSB8IDIwMjhFIHwgMjAyOUUgfCAyMDMwRSB8CnwtLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18Cnwg6ZSA5ZSu5pS25YWlIHwgMTAxICAgIHwgNDE1ICAgIHwgODQxICAgIHwgOTY4ICAgIHwgMTAxMSAgIHwgMTA1NCAgIHwgMTA5NyAgIHwKfCB5b3kgIHwgMzA4LjYyJXwgMTAyLjgyJXwgMTUuMDklIHwgNC40NCUgIHwgNC4yNiUgIHwgNC4wOSUgIHwgICAgICAgIHwKfCDnjrDph5HmtYEgfCAxMiAgICAgfCA1NiAgICAgfCAxMTQgICAgfCAxNTUgICAgfCAxNTMgICAgfCAxNTEgICAgfCAxNDkgICAgfAp8IOaIkOWKn+eOhyB8IDkwJSAgICB8ICAgICAgICB8ICAgICAgICB8ICAgICAgICB8ICAgICAgICB8ICAgICAgICB8ICAgICAgICB8CnwgV0FDQyB8IDUuNjglICB8ICAgICAgICB8ICAgICAgICB8ICAgICAgICB8ICAgICAgICB8ICAgICAgICB8ICAgICAgICB8Cnwg5rC457ut5aKe6ZW/546HIHwgMC44MCUgIHwgICAgICAgIHwgICAgICAgIHwgICAgICAgIHwgICAgICAgIHwgICAgICAgIHwgICAgICAgIHwKfCBEQ0YgfCAzNDgxICAgfCAgICAgICAgfCAgICAgICAgfCAgICAgICAgfCAgICAgICAgfCAgICAgICAgfCAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5aWz5oCn5Lmz6IW655mM5rWB6KGM55eF5a2m6LaL5Yq/5Y+K5Y2x6Zmp5Zug57Sg56CU56m26L+b5bGV77yM5Zu96YeR6K+B5Yi456CU56m25omA
收藏
行业数据
2023-07-04
原图定位
查看详情
ARX788临床I期研究不良反应情况
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
收藏
行业数据
2021-09-26
原图定位
查看详情
ARX788、T-DM1、DS-8201、RC48治疗乳腺癌临床结果对比
收藏
行业数据
2021-06-24
原图定位
查看详情
ARX788、T-DM1、DS-8201、RC48治疗乳腺癌临床结果对比
收藏
行业数据
2021-03-15
原图定位
查看详情
ARX788的ORR随着剂量爬坡明显提升
收藏
行业数据
2020-09-30
原图定位
查看详情
ARX788最常见不良反应(所有级别,发生率>20%)
收藏
行业数据
2020-09-30
原图定位
查看详情
ARX788一期临床数据-安全性(常见副作用发生率)
收藏
行业数据
2020-07-30
原图定位
查看详情
ARX788最常见不良反应(所有级别,发生率>20%)
收藏
行业数据
2020-07-30
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
公司于 2015年-2016年在澳大利亚、新西兰开展了 ARX788的 I期临床试验;本项目的合作方 Ambrx公司于 2016年 8月获准在美国开展 ARX788的 I期临床研究,Ambrx公司发起了一项多中心 I期临床研究,目前正同时在美国和澳大利亚顺利进行中。
行业数据
原图定位
当前图表所属:
【公司研究】浙江医药-维生素与原料:制剂一体化双轮驱动创新药ADC即将步入Ⅱ、Ⅲ期-20200702[25页].pdf
公司一致性评价进展
公司发展历程
2019年公司员工学历分布情况
2011-2019研发投入(百万元)、增速及占收入比重(右轴)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》